Keywords: ANRS, the French National Agency for Research on AIDS; ART, Antiretroviral Therapy; CAPRISA, Centre for the AIDS Programme of Research in South Africa; CRS, Clinical Research Site; EVD, Ebola Virus Disease; HIV, Human Immunodeficiency Syndrome; HPTN, HIV Prevention Trials Network; IPT, Isoniazid Preventive Therapy; LA, long-acting; MAb114, single human monoclonal antibody derived from an Ebola survivor; PrEP, Pre-Exposure Prophylaxis; REGN-EB3, a co-formulated mixture of three human IgG1 monoclonal antibodies; RNA, Ribonucleic Acid; TB, Tuberculosis; Tasp, Treatment as prevention; WHO, World Health Organization; ZMapp, a triple monoclonal antibody agent against Ebola glycoproteins; rVSV, recombinant vesicular stomatitis virus.